ICD code E78.5 – Unspecified hyperlipidemia

Key takeaways

E78.5 codes hyperlipidemia when the note names no lipid subtype. It is the residual code in category E78, not the default one.

When the physician documents a subtype, the specific code replaces E78.5: E78.00, an E78.01- familial code, E78.1, E78.2, E78.41 or E78.49.

Hyperlipidemia caused by hypothyroidism, a drug or another condition is coded with that cause sequenced first and the lipid code after it.

Pabau’s claims management software keeps imported lab results and the claim on one patient record, so the coder sees the lipid values before choosing E78.5.

ICD-10 Code E78.5: Definition and official descriptor

ICD-10 Code E78.5 is the billable ICD-10-CM code for hyperlipidemia, unspecified, the official descriptor in the CMS tabular list. It is billable and specific, so it can stand alone as a diagnosis on a claim.

“Unspecified” means the physician documented elevated lipids but didn’t name the subtype. The note doesn’t say whether it is pure hypercholesterolemia, hyperglyceridemia or mixed hyperlipidemia. When the chart does name one of those, E78.5 is the wrong code.

What E78.5 covers: Inclusions and applicable diagnoses

E78.5 applies when the physician documents elevated lipids without saying which fraction is mainly abnormal. Use it in these scenarios:

• Elevated total cholesterol documented without a split between LDL and HDL
• Dyslipidemia or hyperlipidemia on the problem list with no subtype named
• An abnormal lipid panel where the physician hasn’t assigned a clinical subtype in the note
• Hyperlipidemia listed as a secondary diagnosis beside a cardiovascular or metabolic condition
• HLD recorded as an active problem at a chronic disease visit, with no refined diagnosis

The code often appears as a secondary diagnosis. Take a patient seen for hypertension whose chart lists hyperlipidemia on statin therapy. If no lipid subtype is documented, E78.5 is the right secondary code.

What E78.5 does not cover: Exclusions and secondary causes

E78.5 is a residual code. The ICD-10-CM tabular list and the AAPC ICD-10-CM coding reference both treat it that way. Whenever the documentation supports a more specific code, that code wins.

Specificity rule: The ICD-10-CM Official Guidelines require coding to the highest level of specificity the documentation supports. If the physician writes “pure hypercholesterolemia,” E78.00 applies, or an E78.01- code when it is familial.

Secondary hyperlipidemia: When E78.5 alone is not appropriate

Secondary dyslipidemia comes from an underlying condition such as thyroid disease, diabetes, drug therapy or kidney disease. It is not a primary disorder of lipid metabolism, so the sequencing guidelines put the underlying condition first.

E78.5 can still appear on that claim, as a secondary code after the causal diagnosis. Listing E78.5 first when the documentation points to a secondary cause is a common audit finding and denial trigger.

E78.5 vs. other E78 codes: When to use which

Category E78 holds more than a dozen billable codes, and the subtype the physician documents decides between them. The chart below follows the order a coder reads the note in: the subtype first, then any underlying cause.

The table lists the codes most likely to replace E78.5 when the documentation supports them.

CMS publishes the full code set in its ICD-10 code files, updated each fiscal year. Check E78 subcategory boundaries there, since FY 2026 split the familial code into three.

Documentation requirements for E78.5

E78.5 needs documentation that establishes the diagnosis and shows why no more specific code applies. Payers look for four elements in the chart.

• Lipid panel results: A fasting or non-fasting lipid panel with total cholesterol, LDL, HDL and triglycerides recorded in the chart
• Physician’s assessment: An explicit diagnosis such as hyperlipidemia, elevated lipids, dyslipidemia or HLD in the assessment or problem list
• Treatment decision: A statin order, a dietary counseling referral or the reasoning for watchful waiting, which shows the finding was managed
• Why no subtype is named: A short note when results are borderline or the physician chose not to subtype. It protects the claim from a specificity challenge

If the physician documents hypercholesterolemia beside an LDL of 160 mg/dL and normal triglycerides, the code is E78.00, not E78.5. When the values point to a subtype but the note doesn’t name one, query the physician. A coder can’t assign a subtype from lab values alone.

Common comorbidities coded alongside ICD-10 Code E78.5

Hyperlipidemia rarely appears as the only diagnosis. These conditions are often documented alongside E78.5, and each needs correct sequencing to keep the claim clean.

E78.5 is paired with essential hypertension, I10, at many chronic disease visits. Both codes belong on the claim when both conditions are managed in the encounter, sequenced by the reason for the visit.

Payer requirements for E78.5 claims

Payers treat E78.5 differently depending on the service it supports. For Medicare, National Coverage Determinations (NCDs) and Local Coverage Determinations (LCDs) set which services are paid when E78.5 is the supporting diagnosis.

Medicare and Medicaid: Medicare covers the lipid panel, billed as CPT 80061, with E78.5 for diagnosis and monitoring, subject to frequency limits. E78.5 alone may not establish medical necessity for high-cost drugs such as PCSK9 inhibitors.

Plans usually want documented LDL values, a prior statin trial and a cardiovascular risk assessment before they approve those drugs. Check the plan’s current criteria before you submit.

Commercial payers: Requirements vary by plan. Many accept E78.5 for routine lipid management but want extra diagnosis codes, such as cardiovascular risk codes, before they authorize high-cost drugs. Your revenue cycle management workflow should include a payer-specific check for E78.5 encounters that involve specialty drugs.

Why E78.5 claims get denied and how to prevent it

E78.5 denials follow the same pattern across payers. Most come from one of four sources:

• A more specific E78 code was supported but not used
• The lipid panel is missing from the documentation
• E78.5 was listed first when a causal condition exists
• The claim involved a high-cost drug that needed extra supporting codes

Good denial management workflows for E78.5 start at the point of coding, not at the remittance. A claim that reaches the payer with an under-specified code is far harder to overturn on appeal than one corrected before submission.

When a lipid claim does come back, the reason code on the remittance tells you what to fix. Our list of denial codes explains each CARC and RARC you are likely to see.

A clean E78.5 claim carries four things:

• The diagnosis code at the right level of specificity
• The supporting lipid panel values referenced in the encounter
• The treatment decision documented in the note
• Correct sequencing when comorbidities are present

Our guide to the clean claim covers the rest of the pre-submission checklist.

How Pabau supports accurate E78.5 claims

A coder who can’t see the lipid panel can only code what the problem list says. When results sit in a lab portal or a scanned PDF, E78.5 becomes the easy pick, even when the values point to E78.1 or E78.2.

Pabau, the practice management and EHR platform we build, puts the lab result and the claim on one record. Practices that switch on lab integrations get Quest and Labcorp results imported onto the patient record automatically.

A trends chart on that record shows each result over time, so the coder can check for a named subtype before picking the code.

Claims go out from the same record through our claims management software. It submits through the Claim.MD clearinghouse, which connects to over 4,000 US payers for claims submission, with real-time eligibility for 400+ payers.

ERA remittances post back to the patient, so a specificity denial on an E78.5 line shows up against the encounter that caused it. The billing team corrects the code with the note in front of them instead of chasing the chart later.

Code lipid claims from the lab result

Pabau puts imported lab results, the physician’s assessment and the claim on one patient record. Your coder sees the lipid subtype before choosing E78.5, and the claim goes out through Claim.MD.

Book a demo

Conclusion

E78.5 is the right code only when the note names no lipid subtype. A physician who writes hypercholesterolemia, hyperglyceridemia or mixed hyperlipidemia has already chosen a more specific code for you.

The practical step is to read the note and the lipid panel together before coding. Where they disagree, query the physician rather than default to E78.5. That check takes a minute per claim and heads off the specificity denial before the payer sees it.

Book a demo to see how Pabau keeps lab results, the physician’s note and the claim on one record for your coding team.

Continue your research

Preparing for a payer audit? Medical billing compliance outlines the documentation and coding standards an audit checks.

New to the payer side of coding? What is medical billing walks through the path from encounter to payment.

Coding coronary artery disease alongside E78.5? ICD-10 code I25.10 covers atherosclerotic heart disease without angina and how it is sequenced.

Frequently asked questions